STOCK MARKET BSE NSE

COVAXIN effective against COVID strains found in India, UK: Bharat Biotech

As per an infographic, a modest reduction in neutralisation by a factor of 1.95 was observed against the B.1.617 variant compared to the vaccine variant.

Published: 16th May 2021 01:54 PM  |   Last Updated: 16th May 2021 01:57 PM   |  A+A-

A health official shows Covaxin dose

A health official shows Covaxin dose. (File photo| Shekhar Yadav, EPS)

By ANI

NEW DELHI: Vaccination with Bharat Biotech's COVID-19 vaccine - COVAXIN, has produced neutralising titres (concentration) against all key emerging variants tested, including the B.1.617 and B.1.1.7, first identified in India and the United Kingdom, the vaccine manufacturer informed on Sunday.

As per an infographic, a modest reduction in neutralisation by a factor of 1.95 was observed against the B.1.617 variant compared to the vaccine variant (D614G).

ALSO READ| Six-week gap must for second Covaxin shot: Karnataka COVID Task Force

However, it added that despite this reduction, neutralizing titre levels with B.1.617 remain above levels expected to be protective. "No difference in neutralization between B.1.1.7 (first found in the UK) and vaccine strain (D614G) was observed," Bharat Biotech added.

These findings are from a study conducted in collaboration with the National Institute of Virology - India Council of Medical Research. COVAXIN is one of the three COVID-19 vaccines that are currently available in the country.

As per the Union Health Ministry, a total of 18,22,20,164 doses of COVID-19 vaccines have been administered across the country so far.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp